CAJ | 학술논문

A novel mononuclear Ho(Ⅲ) nitronyl nitroxide complex [Ho(hfac)3(NITPhDma)2], (NITPhDma=2-(4-dimethylamino-phenyl)-4,4,5,5-tetramethylimidazoline-1 -oxyl-3-oxide, hfac=hexafluoroacetylacetonate), was synthesized and structurally characterized by X-ray diffraction. It crystallizes in monoclinic, space group P21/n with a=1.2745(1) nm, 6=1.753 1(2) nm, c=2.4828(2) nm,β=93.753(2)°. The Ho(Ⅲ) ion is eight-coordinated with a distorted dodecahedron environment. Each NITPhDma radical acts as monodentate ligand towards Ho(Ⅲ) ion through the NO group, and the complex molecules are well isolated. CCDC: 775839.
A novel mononuclear Ho(Ⅲ) nitronyl nitroxide complex [Ho(hfac)3(NITPhDma)2], (NITPhDma=2-(4-dimethylamino-phenyl)-4,4,5,5-tetramethylimidazoline-1 -oxyl-3-oxide, hfac=hexafluoroacetylacetonate), was synthesized and structurally characterized by X-ray diffraction. It crystallizes in monoclinic, space group P21/n with a=1.2745(1) nm, 6=1.753 1(2) nm, c=2.4828(2) nm,β=93.753(2)°. The Ho(Ⅲ) ion is eight-coordinated with a distorted dodecahedron environment. Each NITPhDma radical acts as monodentate ligand towards Ho(Ⅲ) ion through the NO group, and the complex molecules are well isolated. CCDC: 775839.
A novel mononuclear Ho(Ⅲ) nitronyl nitroxide complex [Ho(hfac)3(NITPhDma)2], (NITPhDma=2-(4-dimethylamino-phenyl)-4,4,5,5-tetramethylimidazoline-1 -oxyl-3-oxide, hfac=hexafluoroacetylacetonate), was synthesized and structurally characterized by X-ray diffraction. It crystallizes in monoclinic, space group P21/n with a=1.2745(1) nm, 6=1.753 1(2) nm, c=2.4828(2) nm,β=93.753(2)°. The Ho(Ⅲ) ion is eight-coordinated with a distorted dodecahedron environment. Each NITPhDma radical acts as monodentate ligand towards Ho(Ⅲ) ion through the NO group, and the complex molecules are well isolated. CCDC: 775839.